
|Articles|November 28, 2012
Protein predicts post-RP cancer recurrence, death
Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent report.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Kristen Scarpato, MD, on combination strategies in BCG-naïve NMIBC
2
FDA updates in urology: January 2026
3
Trial to compare 225Ac-PSMA-617 vs 177Lu-PSMA-617 for oligorecurrent prostate cancer
4
FDA premarket approval sought for Signatera CDx test in MIBC
5






